Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,054.23 +35.84 (+0.71%) Dow
38,134.08 +230.79 (+0.61%) Nasdaq
15,747.12 +141.64 (+0.91%) Bitcoin USD
58,725.17 +1,066.06 (+1.85%) CMC Crypto 200
1,263.99 -6.75 (-0.53%)
MorphoSys AG (0NDV.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
As of 02:15PM BST. Market open.
| Previous close | 66.50 |
| Open | 65.50 |
| Bid | 64.40 x 0 |
| Ask | 67.70 x 0 |
| Day's range | 65.43 - 66.10 |
| 52-week range | 8.40 - 68.35 |
| Volume | |
| Avg. volume | 175,974 |
| Market cap | 2.272B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 26.16 |
| EPS (TTM) | 2.51 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireMorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
ZacksNovartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
- Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
© 2024 Yahoo. All rights reserved.